Search Within

Kevin Joseph Curran

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (45)
  2. Journal Article (31)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (78)
  2. Department of Medicine (78)
  3. Hematologic Malignancies, Division of (78)
  4. Pediatrics, Department of (78)
  5. Stem Cell Transplantation and Cellular Therapy Service (78)
  6. GSK Faculty (68)

More Groups

People
  1. Renier Brentjens (47)
  2. Isabelle Riviere (40)
  3. Jae Park (38)
  4. Michel Sadelain (36)
  5. Xiuyan Wang (30)
  6. Nancy Kernan (29)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (6)
  6. 2020 (6)

More Years

Publications
  1. Blood (23)
  2. Bone Marrow Transplantation (9)
  3. Biology of Blood and Marrow Transplantation (6)
  4. Molecular Therapy (5)
  5. Blood Advances (4)
  6. Journal of Clinical Oncology (4)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Nature Publishing Group (19)
  3. Elsevier Inc. (7)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Science Ltd. (3)
  6. American Association for Cancer Research (2)

More Publishers

Results (78)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
    Journal Article

    Pasquini, M. C.; Hu, Z. H.; Curran, K.; Laetsch, T.; Locke, F.; Rouce, R.; Pulsipher, M. A.; Phillips, C. L.; Keating, A.; Frigault, M. J.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save